Physician profile
Paul Spring
NPI 1356431845
$2,666.76
in general payments reported to CMS, 2019-2025
19 companies · $30.52 in 2025
The $30.52 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $758 · 2020: $603 · 2021: $901 · 2022: $301 · 2023: $28.24 · 2024: $45.17 · 2025: $30.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $618.23 | 2019-2022 | |
| Stryker Corporation | $617.22 | 2021-2023 | Xpress Ent Dilation System |
| Medtronic, INC. | $229.82 | 2022-2024 | Stealthstation S8 Platform |
| Medtronic USA, INC. | $194.78 | 2019-2020 | |
| Acclarent, INC | $164.89 | 2019-2021 | |
| Genzyme Corporation | $149.60 | 2019-2025 | |
| Hill Dermaceuticals, INC. | $137.85 | 2020 | |
| Inspire Medical Systems, INC. | $129.41 | 2019 | |
| Intersect Ent, INC. | $129.20 | 2019-2020 | |
| Aerin Medical INC. | $54.89 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $53.44 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $46.98 | 2020 | |
| Alk-Abello, INC | $37.27 | 2019-2020 | |
| Genentech USA, INC. | $28.40 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $16.99 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $16.10 | 2020 | |
| Tactile Systems Technology INC | $15.30 | 2021 | |
| Glenmark Therapeutics INC. | $14.00 | 2019 | |
| Glaxosmithkline, LLC. | $12.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Spring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.